Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	SPD489 40mg
Total, all-cause mortality	SPD489 100mg
Total, all-cause mortality	SPD489 160mg
Total, all-cause mortality	Placebo
Total, other adverse events	SPD489 40mg	0	0
Total, other adverse events	SPD489 100mg	0	0
Total, other adverse events	SPD489 160mg	0	0
Total, other adverse events	Placebo	0	0
Total, serious adverse events	SPD489 40mg	0	0
Total, serious adverse events	SPD489 100mg	0	0
Total, serious adverse events	SPD489 160mg	0	0
Total, serious adverse events	Placebo	0	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01738698/event-totals